Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19

Conditions:   Corona Virus Infection;   Covid19;   SARS-CoV Infection Interventions:   Drug: Placebo administration;   Diagnostic Test: Confirm SARS-CoV-2 infection;   Procedure: Physical Examination;   Procedure: Vital Signs;   Diagnostic Test: Hematology blood test;   Diagnostic Test: Biochemistry blood test;   Other: NEWS score;   Diagnostic Test: P K test;   Diagnostic Test: blood test for inflammatory markers;   Diagnostic Test: D-dimer test;   Other: VAS scale;   Diagnostic Test: Urine pregnancy test for women of childbearing potential;   Procedure: ECG;   Other: COVID-19-Impact on Quality of Life Questionnaire;   Drug: Cimetr A-1;   Drug: CimetrA-2 Sponsor:   MGC Pharmaceuticals d.o.o Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials